Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer (TavIx)
This study is ongoing, but not recruiting participants.
Sponsor:
UNICANCER
Information provided by (Responsible Party):
UNICANCER
ClinicalTrials.gov Identifier:
NCT00630032
First received: March 5, 2008
Last updated: July 20, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |